- Home
- KRNY vs XOMA Comparison
KRNY vs XOMA Comparison
Compare KRNY & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- XOMA
- Stock Information
- Founded
- KRNY 1884
- XOMA 1981
- Country
- KRNY United States
- XOMA United States
- Employees
- KRNY N/A
- XOMA N/A
- Industry
- KRNY Savings Institutions
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- XOMA Health Care
- Exchange
- KRNY Nasdaq
- XOMA Nasdaq
- Market Cap
- KRNY 416.3M
- XOMA 457.6M
- IPO Year
- KRNY 2005
- XOMA N/A
- Fundamental
- Price
- KRNY $6.39
- XOMA $32.98
- Analyst Decision
- KRNY Buy
- XOMA Strong Buy
- Analyst Count
- KRNY 2
- XOMA 2
- Target Price
- KRNY $7.75
- XOMA $69.50
- AVG Volume (30 Days)
- KRNY 395.0K
- XOMA 45.9K
- Earning Date
- KRNY 10-23-2025
- XOMA 11-05-2025
- Dividend Yield
- KRNY 6.84%
- XOMA N/A
- EPS Growth
- KRNY N/A
- XOMA N/A
- EPS
- KRNY 0.47
- XOMA N/A
- Revenue
- KRNY $158,298,000.00
- XOMA $44,952,000.00
- Revenue This Year
- KRNY $14.22
- XOMA $88.91
- Revenue Next Year
- KRNY N/A
- XOMA $13.80
- P/E Ratio
- KRNY $13.59
- XOMA N/A
- Revenue Growth
- KRNY 23.27
- XOMA 194.98
- 52 Week Low
- KRNY $5.45
- XOMA $18.35
- 52 Week High
- KRNY $8.59
- XOMA $39.92
- Technical
- Relative Strength Index (RSI)
- KRNY 42.18
- XOMA 38.64
- Support Level
- KRNY $6.41
- XOMA $32.30
- Resistance Level
- KRNY $6.65
- XOMA $35.71
- Average True Range (ATR)
- KRNY 0.18
- XOMA 1.65
- MACD
- KRNY -0.03
- XOMA -0.40
- Stochastic Oscillator
- KRNY 9.84
- XOMA 10.15
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.